|
|
|
|
|
|
|
05.06.25 - 13:31
|
Regenxbio′s Gene Therapy Helps Kids with Deadly Muscle Disease (Bloomberg)
|
|
|
Children with a deadly muscle disorder had more control of their bodies after getting an experimental gene therapy from Regenxbio Inc. in a small study. The results foreshadow a potential rivalry with Sarepta Therapeutics Inc. and a critical test for the Trump administration's new drug regulators....
|
|
|
|
|
|
|
|
|
|
|
|
|
14.05.25 - 13:48
|
FDA to review Regenxbio’s gene therapy BLA for Hunter syndrome (PBR)
|
|
|
The agency has granted the application priority review, setting a Prescription Drug User Fee Act (PDUFA) target action date of 9 November 2025. The therapy has secured several
The post FDA to review Regenxbio's gene therapy BLA for Hunter syndrome appeared first on Pharmaceutical Business review....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
08.05.25 - 14:30
|
Max Trading-Meisterstück – min. +34% dank perfekt getimtem Ausstieg (Sharedeals)
|
|
|
Biotech-Vollprofi Maximilian Ruth beweist wieder sein goldenes Händchen! Seine Regenxbio-Empfehlung brachte sharedealsPlus-Mitgliedern mindestens +34% in nur drei Monaten – und das Ausstiegssignal kam genau im richtigen Moment. Ein Paradebeispiel für präzises Markt-Timing. Unser Experte für die aufregende Welt der Biotechnologie hat erneut zugeschlagen! Maximilian Ruth, der unbestrittene Biotech-Kenner und Chefanalyst des exklusiven Anlegerzirkels No Brainer […]
The post Max' Trading-Meisterstück – min. +34% dank perfekt getimtem Ausstieg first appeared on sharedeals.de....
|
|
|
|
|
06.05.25 - 13:09
|
REGENXBIO to Participate in Upcoming Investor Conferences (PR Newswire)
|
|
|
ROCKVILLE, Md., May 6, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following investor conferences: BofA Securities Health Care Conference 2025 Presentation: Tuesday, May 13, 2025 at 5:00 p.m. PT Location: Las Vegas, NV RBC Global......
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
